Discovering potential inhibitors of Raf proto-oncogene serine/threonine kinase 1: a virtual screening approach towards anticancer drug development

References

• Abraham, M. J., Murtola, T., Schulz, R., Páll, S., Smith, J. C., Hess, B., & Lindahl, E. (2015). GROMACS: High performance molecular simulations through multi-level parallelism from laptops to supercomputers. SoftwareX, 1–2, 19–25. https://doi.org/10.1016/j.softx.2015.06.001
   Google Scholar
• Adnan, M., Koli, S., Mohammad, T., Siddiqui, A. J., Patel, M., Alshammari, N., Bardakci, F., Elasbali, A. M., & Hassan, M. I. (2022). Searching for novel anaplastic lymphoma kinase inhibitors: Structure-guided screening of natural compounds for a tyrosine kinase therapeutic target in cancers. Omics, 26(8), 461–470. https://doi.org/10.1089/omi.2022.0067
   PubMed Web of Science ®Google Scholar
• Anjum, F., Mohammad, T., Almalki, A. A., Akhtar, O., Abdullaev, B., & Hassan, M. I. (2021). Phytoconstituents and medicinal plants for anticancer drug discovery: Computational identification of potent inhibitors of PIM1 kinase. Omics, 25(9), 580–590. https://doi.org/10.1089/omi.2021.0107
   PubMed Web of Science ®Google Scholar
• Anjum, F., Sulaimani, M. N., Shafie, A., Mohammad, T., Ashraf, G. M., Bilgrami, A. L., Alhumaydhi, F. A., Alsagaby, S. A., Yadav, D. K., & Hassan, M. I. (2022). Bioactive phytoconstituents as potent inhibitors of casein kinase-2: Dual implications in cancer and COVID-19 therapeutics. RSC Advances, 12(13), 7872–7882. https://doi.org/10.1039/d1ra09339hd1ra09339h[pii]
   PubMed Web of Science ®Google Scholar
• Anwar, S., Khan, S., Shamsi, A., Anjum, F., Shafie, A., Islam, A., Ahmad, F., & Hassan, M. I. (2021). Structure-based investigation of MARK4 inhibitory potential of Naringenin for therapeutic management of cancer and neurodegenerative diseases. Journal of Cellular Biochemistry, 122(10), 1445–1459. https://doi.org/10.1002/jcb.30022
   PubMed Web of Science ®Google Scholar
• Anwar, S., Mohammad, T., Shamsi, A., Queen, A., Parveen, S., Luqman, S., Hasan, G. M., Alamry, K. A., Azum, N., Asiri, A. M., & Hassan, M. I. (2020). Discovery of hordenine as a potential inhibitor of pyruvate dehydrogenase kinase 3: Implication in lung cancer therapy. Biomedicines, 8(5), 119. https://doi.org/10.3390/biomedicines8050119119
   PubMed Web of Science ®Google Scholar
• Anwar, S., Shamsi, A., Kar, R. K., Queen, A., Islam, A., Ahmad, F., & Hassan, M. I. (2020). Structural and biochemical investigation of MARK4 inhibitory potential of cholic acid: Towards therapeutic implications in neurodegenerative diseases. International Journal of Biological Macromolecules, 161, 596–604. https://doi.org/10.1016/j.ijbiomac.2020.06.078
   PubMed Web of Science ®Google Scholar
• Anwar, S., Shamsi, A., Shahbaaz, M., Queen, A., Khan, P., Hasan, G. M., Islam, A., Alajmi, M. F., Hussain, A., Ahmad, F., & Hassan, M. I. (2020). Rosmarinic acid exhibits anticancer effects via MARK4 inhibition. Scientific Reports, 10(1), 10300. https://doi.org/10.1038/s41598-020-65648-z
   PubMed Web of Science ®Google Scholar
• Avti, P., Chauhan, A., Shekhar, N., Prajapat, M., Sarma, P., Kaur, H., Bhattacharyya, A., Kumar, S., Prakash, A., Sharma, S., & Medhi, B. (2022). Computational basis of SARS-CoV 2 main protease inhibition: An insight from molecular dynamics simulation based findings. Journal of Biomolecular Structure and Dynamics, 40(19), 8894–8904. https://doi.org/10.1080/07391102.2021.1922310
   PubMed Web of Science ®Google Scholar
• Biovia, D. S. (2017). Discovery studio visualizer.
   Google Scholar
• Bonner, T., O'Brien, S. J., Nash, W. G., Rapp, U. R., Morton, C. C., & Leder, P. (1984). The human homologs of the Raf (mil) oncogene are located on human chromosomes 3 and 4. Science (New York, N.Y.), 223(4631), 71–74. https://doi.org/10.1126/science.6691137
   PubMed Web of Science ®Google Scholar
• Borovski, T., Vellinga, T. T., Laoukili, J., Santo, E. E., Fatrai, S., van Schelven, S., Verheem, A., Marvin, D. L., Ubink, I., Borel Rinkes, I. H. M., & Kranenburg, O. (2017). Inhibition of RAF1 kinase activity restores apicobasal polarity and impairs tumour growth in human colorectal cancer. Gut, 66(6), 1106–1115. https://doi.org/10.1136/gutjnl-2016-311547
   PubMed Web of Science ®Google Scholar
• Caron, G., Kihlberg, J., Goetz, G., Ratkova, E., Poongavanam, V., & Ermondi, G. (2021). Steering new drug discovery campaigns: Permeability, solubility, and physicochemical properties in the bro5 chemical space. ACS Medicinal Chemistry Letters, 12(1), 13–23. https://doi.org/10.1021/acsmedchemlett.0c00581
   PubMed Web of Science ®Google Scholar
• Chen, L., Wang, Q., Wang, G. D., Wang, H. S., Huang, Y., Liu, X. M., & Cai, X. H. (2013). miR-16 inhibits cell proliferation by targeting IGF1R and the Raf1-MEK1/2-ERK1/2 pathway in osteosarcoma. FEBS Letters, 587(9), 1366–1372. https://doi.org/10.1016/j.febslet.2013.03.007
   PubMed Web of Science ®Google Scholar
• Chong, H., Vikis, H. G., & Guan, K. L. (2003). Mechanisms of regulating the Raf kinase family. Cellular Signalling, 15(5), 463–469. https://doi.org/10.1016/s0898-6568(02)00139-0
   PubMed Web of Science ®Google Scholar
• Cobb, M. H., Hepler, J. E., Cheng, M., & Robbins, D. (1994). The mitogen-activated protein kinases, ERK1 and ERK2. Seminars in Cancer Biology, 5(4), 261–268.
   PubMed Web of Science ®Google Scholar
• Cookis, T., & Mattos, C. (2021). Crystal structure reveals the full Ras-Raf interface and advances mechanistic understanding of Raf activation. Biomolecules, 11(7), 996. https://doi.org/10.3390/biom11070996
   PubMed Web of Science ®Google Scholar
• Dahiya, R., Mohammad, T., Roy, S., Anwar, S., Gupta, P., Haque, A., Khan, P., Kazim, S. N., Islam, A., Ahmad, F., & Hassan, M. I. (2019). Investigation of inhibitory potential of quercetin to the pyruvate dehydrogenase kinase 3: Towards implications in anticancer therapy. International Journal of Biological Macromolecules, 136, 1076–1085. https://doi.org/10.1016/j.ijbiomac.2019.06.158
   PubMed Web of Science ®Google Scholar
• Daina, A., Michielin, O., & Zoete, V. (2017). SwissADME: A free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Scientific Reports, 7(1), 1–13. https://doi.org/10.1038/srep42717
   PubMed Web of Science ®Google Scholar
• DeLano, W. L. (2002). Pymol: An open-source molecular graphics tool. CCP4 Newsl. Protein Crystallogr, 40, 82–92.
   Google Scholar
• Freedland, S. J., & Aronson, W. J. (2017). Commentary on “Integrative clinical genomics of advanced prostate cancer”. Robinson D, Van Allen EM, Wu YM, Schultz N, Lonigro RJ, Mosquera JM, Montgomery B, Taplin ME, Pritchard CC, Attard G, Beltran H, Abida W, Bradley RK, Vinson J, Cao X, Vats P, Kunju LP, Hussain M, Feng FY, Tomlins SA, Cooney KA, Smith DC, Brennan C, Siddiqui J, Mehra R, Chen Y, Rathkopf DE, Morris MJ, Solomon SB, Durack JC, Reuter VE, Gopalan A, Gao J, Loda M, Lis RT, Bowden M, Balk SP, Gaviola G, Sougnez C, Gupta M, Yu EY, Mostaghel EA, Cheng HH, Mulcahy H, True LD, Plymate SR, Dvinge H, Ferraldeschi R, Flohr P, Miranda S, Zafeiriou Z, Tunariu N, Mateo J, Perez-Lopez R, Demichelis F, Robinson BD, Schiffman M, Nanus DM, Tagawa ST, Sigaras A, Eng KW, Elemento O, Sboner A, Heath EI, Scher HI, Pienta KJ, Kantoff P, de Bono JS, Rubin MA, Nelson PS, Garraway LA, Sawyers CL, Chinnaiyan AM.Cell. 21 May 2015;161(5):1215–1228. Urologic Oncology, 35(8), 535. https://doi.org/10.1016/j.urolonc.2017.05.010
   PubMedGoogle Scholar
• Genheden, S., & Ryde, U. (2015). The MM/PBSA and MM/GBSA methods to estimate ligand-binding affinities. Expert Opinion on Drug Discovery, 10(5), 449–461. https://doi.org/10.1517/17460441.2015.1032936
   PubMed Web of Science ®Google Scholar
• Gollob, J. A., Wilhelm, S., Carter, C., & Kelley, S. L. (2006). Role of Raf kinase in cancer: Therapeutic potential of targeting the Raf/MEK/ERK signal transduction pathway. Seminars in Oncology, 33(4), 392–406. https://doi.org/10.1053/j.seminoncol.2006.04.002
   PubMed Web of Science ®Google Scholar
• Gupta, P., Khan, S., Fakhar, Z., Hussain, A., Rehman, M. T., AlAjmi, M. F., Islam, A., Ahmad, F., & Hassan, M. I. (2020). Identification of potential inhibitors of calcium/calmodulin-dependent protein kinase IV from bioactive phytoconstituents. Oxidative Medicine and Cellular Longevity, 2020, 2094635. https://doi.org/10.1155/2020/2094635
   PubMed Web of Science ®Google Scholar
• Gupta, P., Mohammad, T., Dahiya, R., Roy, S., Noman, O. M. A., Alajmi, M. F., Hussain, A., & Hassan, M. I. (2019). Evaluation of binding and inhibition mechanism of dietary phytochemicals with sphingosine kinase 1: Towards targeted anticancer therapy. Scientific Reports, 9(1), 18727. https://doi.org/10.1038/s41598-019-55199-3
   PubMedGoogle Scholar
• Hekman, M., Wiese, S., Metz, R., Albert, S., Troppmair, J., Nickel, J., Sendtner, M., & Rapp, U. R. (2004). Dynamic changes in C-Raf phosphorylation and 14-3-3 protein binding in response to growth factor stimulation: Differential roles of 14-3-3 protein binding sites. The Journal of Biological Chemistry, 279(14), 14074–14086. https://doi.org/10.1074/jbc.M309620200
   PubMed Web of Science ®Google Scholar
• Hernández-Rodríguez, M., Rosales-Hernández, M. C., Mendieta-Wejebe, J. E., Martínez-Archundia, M., & Correa Basurto, J. (2016). Current tools and methods in molecular dynamics (MD) simulations for drug design. Current Medicinal Chemistry, 23(34), 3909–3924. https://doi.org/10.2174/0929867323666160530144742
   PubMed Web of Science ®Google Scholar
• Hoda, N., Naz, H., Jameel, E., Shandilya, A., Dey, S., Hassan, M. I., Ahmad, F., & Jayaram, B. (2016). Curcumin specifically binds to the human calcium-calmodulin-dependent protein kinase IV: Fluorescence and molecular dynamics simulation studies. Journal of Biomolecular Structure & Dynamics, 34(3), 572–584. https://doi.org/10.1080/07391102.2015.1046934
   PubMed Web of Science ®Google Scholar
• Hu, J., Stites, E. C., Yu, H., Germino, E. A., Meharena, H. S., Stork, P. J. S., Kornev, A. P., Taylor, S. S., & Shaw, A. S. (2013). Allosteric activation of functionally asymmetric RAF kinase dimers. Cell, 154(5), 1036–1046. https://doi.org/10.1016/j.cell.2013.07.046
   PubMed Web of Science ®Google Scholar
• Huey, R., Morris, G. M., & Forli, S. (2012). Using AutoDock 4 and AutoDock vina with AutoDockTools: A tutorial. The Scripps Research Institute Molecular Graphics Laboratory, 10550, 92037.
   Google Scholar
• Hünenberger, P., Mark, A., & Van Gunsteren, W. (1995). Fluctuation and cross-correlation analysis of protein motions observed in nanosecond molecular dynamics simulations. Journal of Molecular Biology, 252(4), 492–503. https://doi.org/10.1006/jmbi.1995.0514
   PubMed Web of Science ®Google Scholar
• Hung, C. L., & Chen, C. C. (2014). Computational approaches for drug discovery. Drug Development Research, 75(6), 412–418. https://doi.org/10.1002/ddr.21222
   PubMed Web of Science ®Google Scholar
• Hwang, Y. H., Choi, J. Y., Kim, S., Chung, E. S., Kim, T., Koh, S. S., Lee, B., Bae, S. H., Kim, J., & Park, Y. M. (2004). Over-expression of c-raf-1 proto-oncogene in liver cirrhosis and hepatocellular carcinoma. Hepatology Research, 29(2), 113–121. https://doi.org/10.1016/j.hepres.2004.02.009
   PubMed Web of Science ®Google Scholar
• Jemal, A., Bray, F., Center, M. M., Ferlay, J., Ward, E., & Forman, D. (2011). Global cancer statistics. CA: A Cancer Journal for Clinicians, 61(2), 69–90. https://doi.org/10.3322/caac.20107
   PubMed Web of Science ®Google Scholar
• Jiang, Q., Cheng, L., Ma, D., & Zhao, Y. (2019). FBXL19-AS1 exerts oncogenic function by sponging miR-431-5p to regulate RAF1 expression in lung cancer. Bioscience Reports, 39(1), BSR20181804. https://doi.org/10.1042/BSR20181804
   Google Scholar
• Khan, P., Queen, A., Mohammad, T., Smita, Khan, N. S., Hafeez, Z. B., Hassan, M. I., & Ali, S. (2019). Identification of alpha-mangostin as a potential inhibitor of microtubule affinity regulating kinase 4. Journal of Natural Products, 82(8), 2252–2261., https://doi.org/10.1021/acs.jnatprod.9b00372
   PubMed Web of Science ®Google Scholar
• Kordi-Tamandani, D. M., Saberi, E., Jamali, S., & Ladiz, M. A. (2014). ERK and RAF1 genes: Analysis of methylation and expression profiles in patients with oral squamous cell carcinoma. British Journal of Biomedical Science, 71(3), 100–103. https://doi.org/10.1080/09674845.2014.11669972
   PubMed Web of Science ®Google Scholar
• Kyriakis, J. M., App, H., Zhang, X. F., Banerjee, P., Brautigan, D. L., Rapp, U. R., & Avruch, J. (1992). Raf-1 activates MAP kinase-kinase. Nature, 358(6385), 417–421. https://doi.org/10.1038/358417a0
   PubMed Web of Science ®Google Scholar
• Laberge, M., & Yonetani, T. (2008). Molecular dynamics simulations of hemoglobin A in different states and bound to DPG: Effector-linked perturbation of tertiary conformations and HbA concerted dynamics. Biophysical Journal, 94(7), 2737–2751. https://doi.org/10.1529/biophysj.107.114942
   PubMed Web of Science ®Google Scholar
• Lagunin, A., Stepanchikova, A., Filimonov, D., & Poroikov, V. (2000). PASS: Prediction of activity spectra for biologically active substances. Bioinformatics (Oxford, England), 16(8), 747–748. https://doi.org/10.1093/bioinformatics/16.8.747
   PubMed Web of Science ®Google Scholar
• Leng, Q., & Mixson, A. J. (2005). Small interfering RNA targeting Raf-1 inhibits tumor growth in vitro and in vivo. Cancer Gene Therapy, 12(8), 682–690. https://doi.org/10.1038/sj.cgt.7700831
   PubMed Web of Science ®Google Scholar
• Mahapatra, M. K., Bera, K., Singh, D. V., Kumar, R., & Kumar, M. (2018). In silico modelling and molecular dynamics simulation studies of thiazolidine based PTP1B inhibitors. Journal of Biomolecular Structure & Dynamics, 36(5), 1195–1211. https://doi.org/10.1080/07391102.2017.1317026
   PubMed Web of Science ®Google Scholar
• Matallanas, D., Birtwistle, M., Romano, D., Zebisch, A., Rauch, J., von Kriegsheim, A., & Kolch, W. (2011). Raf family kinases: Old dogs have learned new tricks. Genes & Cancer, 2(3), 232–260. https://doi.org/10.1177/1947601911407323
   PubMedGoogle Scholar
• McCubrey, J. A., Steelman, L. S., Chappell, W. H., Abrams, S. L., Wong, E. W., Chang, F., Lehmann, B., Terrian, D. M., Milella, M., Tafuri, A., Stivala, F., Libra, M., Basecke, J., Evangelisti, C., Martelli, A. M., & Franklin, R. A. (2007). Roles of the Raf/MEK/ERK pathway in cell growth, malignant transformation and drug resistance. Biochimica et Biophysica Acta, 1773(8), 1263–1284. https://doi.org/10.1016/j.bbamcr.2006.10.001
   PubMed Web of Science ®Google Scholar
• McKay, M. M., & Morrison, D. K. (2007). Integrating signals from RTKs to ERK/MAPK. Oncogene, 26(22), 3113–3121. https://doi.org/10.1038/sj.onc.1210394
   PubMed Web of Science ®Google Scholar
• Miller, B. R., III, McGee, Jr., T. D., Swails, J. M., Homeyer, N., Gohlke, H., & Roitberg, A. E. (2012). MMPBSA. py: An efficient program for end-state free energy calculations. Journal of Chemical Theory and Computation, 8(9), 3314–3321. https://doi.org/10.1021/ct300418h
   PubMed Web of Science ®Google Scholar
• Mohammad, T., Khan, F. I., Lobb, K. A., Islam, A., Ahmad, F., & Hassan, M. I. (2019). Identification and evaluation of bioactive natural products as potential inhibitors of human microtubule affinity-regulating kinase 4 (MARK4). Journal of Biomolecular Structure & Dynamics, 37(7), 1813–1829. https://doi.org/10.1080/07391102.2018.1468282
   PubMed Web of Science ®Google Scholar
• Mohammad, T., Mathur, Y., & Hassan, M. I. (2021). InstaDock: A single-click graphical user interface for molecular docking-based virtual high-throughput screening. Briefings in Bioinformatics, 22(4), bbaa279. https://doi.org/10.1093/bib/bbaa279
   PubMed Web of Science ®Google Scholar
• Mohammad, T., Siddiqui, S., Shamsi, A., Alajmi, M. F., Hussain, A., Islam, A., Ahmad, F., & Hassan, M. I. (2020). Virtual screening approach to identify high-affinity inhibitors of serum and glucocorticoid-regulated kinase 1 among bioactive natural products: Combined molecular docking and simulation studies. Molecules, 25(4), 823. https://doi.org/10.3390/molecules25040823
   PubMed Web of Science ®Google Scholar
• Morrison, D. K., & Cutler, R. E. (1997). The complexity of Raf-1 regulation. Current Opinion in Cell Biology, 9(2), 174–179. https://doi.org/10.1016/s0955-0674(97)80060-9
   PubMed Web of Science ®Google Scholar
• Morrison, D. K., Heidecker, G., Rapp, U. R., & Copeland, T. D. (1993). Identification of the major phosphorylation sites of the Raf-1 kinase. The Journal of Biological Chemistry, 268(23), 17309–17316.
   PubMed Web of Science ®Google Scholar
• Muslin, A. J., Tanner, J. W., Allen, P. M., & Shaw, A. S. (1996). Interaction of 14-3-3 with signaling proteins is mediated by the recognition of phosphoserine. Cell, 84(6), 889–897. https://doi.org/10.1016/s0092-8674(00)81067-3
   PubMed Web of Science ®Google Scholar
• Naqvi, A. A. T., Jairajpuri, D. S., Hussain, A., Hasan, G. M., Alajmi, M. F., & Hassan, M. I. (2021). Impact of glioblastoma multiforme associated mutations on the structure and function of MAP/microtubule affinity regulating kinase 4. Journal of Biomolecular Structure & Dynamics, 39(5), 1781–1794. https://doi.org/10.1080/07391102.2020.1738959
   PubMed Web of Science ®Google Scholar
• Naqvi, A. A., Mohammad, T., Hasan, G. M., & Hassan, M. (2018). Advancements in docking and molecular dynamics simulations towards ligand-receptor interactions and structure-function relationships. Current Topics in Medicinal Chemistry, 18(20), 1755–1768. https://doi.org/10.2174/1568026618666181025114157
   PubMed Web of Science ®Google Scholar
• Naz, F., Khan, F. I., Mohammad, T., Khan, P., Manzoor, S., Hasan, G. M., Lobb, K. A., Luqman, S., Islam, A., Ahmad, F., & Hassan, M. I. (2018). Investigation of molecular mechanism of recognition between citral and MARK4: A newer therapeutic approach to attenuate cancer cell progression. International Journal of Biological Macromolecules, 107(Pt B), 2580–2589. https://doi.org/10.1016/j.ijbiomac.2017.10.143
   PubMedGoogle Scholar
• Pires, D. E., Blundell, T. L., & Ascher, D. B. (2015). pkCSM: Predicting small-molecule pharmacokinetic and toxicity properties using graph-based signatures. Journal of Medicinal Chemistry, 58(9), 4066–4072. https://doi.org/10.1021/acs.jmedchem.5b00104
   PubMed Web of Science ®Google Scholar
• Rajakulendran, T., Sahmi, M., Lefrançois, M., Sicheri, F., & Therrien, M. (2009). A dimerization-dependent mechanism drives RAF catalytic activation. Nature, 461(7263), 542–545. https://doi.org/10.1038/nature08314
   PubMed Web of Science ®Google Scholar
• Ren, G., Liu, X., Mao, X., Zhang, Y., Stankiewicz, E., Hylands, L., Song, R., Berney, D. M., Clark, J., Cooper, C., & Lu, Y. J. (2012). Identification of frequent BRAF copy number gain and alterations of RAF genes in Chinese prostate cancer. Genes, Chromosomes & Cancer, 51(11), 1014–1023. https://doi.org/10.1002/gcc.21984
   PubMed Web of Science ®Google Scholar
• Scapin, G. (2006). Structural biology and drug discovery. Current Pharmaceutical Design, 12(17), 2087–2097. https://doi.org/10.2174/138161206777585201
   PubMed Web of Science ®Google Scholar
• Schüttelkopf, A. W., & Van Aalten, D. M. (2004). PRODRG: A tool for high-throughput crystallography of protein–ligand complexes. Acta Crystallographica Section D, Biological Crystallography, 60(Pt 8), 1355–1363. https://doi.org/10.1107/S0907444904011679
   PubMedGoogle Scholar
• Shafie, A., Khan, S., Zehra, Mohammad, T., Anjum, F., Hasan, G. M., Yadav, D. K., & Hassan, M. I. (2021). Identification of phytoconstituents as potent inhibitors of casein kinase-1 alpha using virtual screening and molecular dynamics simulations. Pharmaceutics, 13(12), 2157. https://doi.org/10.3390/pharmaceutics13122157
   PubMed Web of Science ®Google Scholar
• Slattery, M. L., Lundgreen, A., & Wolff, R. K. (2012). MAP kinase genes and colon and rectal cancer. Carcinogenesis, 33(12), 2398–2408. https://doi.org/10.1093/carcin/bgs305
   PubMed Web of Science ®Google Scholar
• Steelman, L. S., Chappell, W. H., Abrams, S. L., Kempf, R. C., Long, J., Laidler, P., Mijatovic, S., Maksimovic-Ivanic, D., Stivala, F., Mazzarino, M. C., Donia, M., Fagone, P., Malaponte, G., Nicoletti, F., Libra, M., Milella, M., Tafuri, A., Bonati, A., Bäsecke, J., … McCubrey, J. A. (2011). Roles of the Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR pathways in controlling growth and sensitivity to therapy-implications for cancer and aging. Aging, 3(3), 192–222. https://doi.org/10.18632/aging.100296
   PubMedGoogle Scholar
• Tran, N. H., & Frost, J. A. (2003). Phosphorylation of Raf-1 by p21-activated kinase 1 and Src regulates Raf-1 autoinhibition. The Journal of Biological Chemistry, 278(13), 11221–11226. https://doi.org/10.1074/jbc.M210318200
   PubMed Web of Science ®Google Scholar
• Weiss, M. S., Brandl, M., Sühnel, J., Pal, D., & Hilgenfeld, R. (2001). More hydrogen bonds for the (structural) biologist. Trends in Biochemical Sciences, 26(9), 521–523. https://doi.org/10.1016/s0968-0004(01)01935-1
   PubMed Web of Science ®Google Scholar
• Wellbrock, C., Karasarides, M., & Marais, R. (2004). The RAF proteins take centre stage. Nature Reviews. Molecular Cell Biology, 5(11), 875–885. https://doi.org/10.1038/nrm1498
   PubMed Web of Science ®Google Scholar
• Widegren, U., Ryder, J., & Zierath, J. (2001). Mitogen‐activated protein kinase signal transduction in skeletal muscle: Effects of exercise and muscle contraction. Acta Physiologica Scandinavica, 172(3), 227–238. https://doi.org/10.1046/j.1365-201x.2001.00855.x
   PubMedGoogle Scholar
• Xu, Z. H., Hang, J. B., Hu, J. A., & Gao, B. L. (2013). RAF1-MEK1-ERK/AKT axis may confer NSCLC cell lines resistance to erlotinib. International Journal of Clinical and Experimental Pathology, 6(8), 1493–1504.
   PubMed Web of Science ®Google Scholar
• Yang, C., Alam, A., Alhumaydhi, F. A., Khan, M. S., Alsagaby, S. A., Al Abdulmonem, W., Hassan, M. I., Shamsi, A., Bano, B., & Yadav, D. K. (2022). Bioactive phytoconstituents as potent inhibitors of tyrosine-protein kinase yes (YES1): Implications in anticancer therapeutics. Molecules, 27(10), 3060. https://doi.org/10.3390/molecules27103060
   PubMed Web of Science ®Google Scholar
• Ye, S., Song, W., Xu, X., Zhao, X., & Yang, L. (2016). IGF2BP2 promotes colorectal cancer cell proliferation and survival through interfering with RAF-1 degradation by miR-195. FEBS Letters, 590(11), 1641–1650. https://doi.org/10.1002/1873-3468.12205
   PubMed Web of Science ®Google Scholar
• Zlobin, A., Bloodworth, J. C., & Osipo, C. (2019). Mitogen-activated protein kinase (MAPK) signaling. Predictive Biomarkers in Oncology: Applications in Precision Medicine, Springer, Cham. 213–221.
   Google Scholar